References
- Lloyd-Jones D, Adams RJ, Brown TM, et al. Executive summary: heart disease and stroke statistics – 2010 update. Circulation 2010;121:948-54
- Mancia G, Fagard R, Narkiewicz K. 2013 ESH/ESC guidelines for the management of arterial hypertension. J Hypertens 2013;31:1281-357
- Mancia G, Laurent S, Agabiti-Rosei E, et al. Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force Document. J Hypertens 2009;7:2121-58
- Klein G. Combination therapy with feldipine and metoptolol compared with captopril and hydrochlorothiazide. Blood Pressure 1998;7:308-12
- Barriosa V, Brommer P Haag U, et al. Olmesartan medoxomil plus amlodipine increases efficacy in patients with moderate-to-severe hypertension after monotherapy. Clin Drug Invest 2009;29:427-39
- Paker M. Combined beta-adrenergic and calcium-entry blockade in angina pectoris. NEJM 1989;32:709-18
- Fox K, Alonso Garcia MA, Ardissino D. Guidelines on the management of stable angina pectoris. Kardiol POL 2006;64:823-80
- Bethge H, Litterer G, Wagner G, et al. 24-Stunden-Wirkung von Bisoprolol auf Ruhe- und Belastungsblutdruck. Fortschr Med 1989;107:153-8
- Smith C, Teitler M. Beta-blocker selectivity at cloned human beta 1- and beta 2- adrenergic receptors. Cardiovasc Drugs Ther 1999;2:123-6
- Nuttall SL, Routledge HC, Kendall MJ. A comparison of the beta1-selectivity of three beta1-selective beta-blockers. J Clin Pharm Ther 2003;28:179-86
- Murdoch D, Heel RC. Amlodipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutics use in cardiovascular diseases. Drugs 1991;41:478-505
- Wellstein A, Palm D, Belz GG. Affinity and selectivity of beta-adrenoceptor antagonists in vitro. J Cardiovasc Pharmacol 1986;8(Suppl 11):S36-40
- Julius S. Amlodipine in hypertension: an overview of the clinical dossier. J Cardiovasc Pharmacol 1988;12(Suppl 7):S27-33
- Mehta S, Shah M, Shah A, et al. Efficacy and tolerability of a fixed dose combination of amlodipin and bisoprolol in essential hypertension. Indian Practitioner 2005;58:751-9
- Rana R, Patil A. Efficacy and safety of bisoprolol plus amlodipine fixed dose combination in essential hypertension. Indian Practitioner 2008;61:225-34
- Shiure PA, Tadvi NA Bajait CS, et al. Comparative effect of fixed dose combination of amlodipine + bisoprolol versus amlodipine and bisoprolol alone on blood pressure in stage-2 essential hypertensive patients. Int J Med Res Health Sci 2012;1:13-19
- Dezii CM. A retrospective study of persistence with single-pill combination therapy vs. concurrent two-pill therapy in patients with hypertension. Manag Care 2000;9(9 Suppl):2-6
- Antonakoudis G, Poulimenos I, Kifnidis K, et al. Blood pressure control and cardiovascular risk reduction. Hippokratia 2007;11:114-19
- Cushman WC, Evans GW, Byington RP, et al. Effects of intensive blood-pressure control in type 2 diabetes mellitus. N Engl J Med 2010;362:1575-85
- Gradman AH, Basile JN, Carter BL, et al. Position article. Combination therapy in hypertension. J A Soc Hypertens 2010;4:42-50
- Oster JR, Epstein M. Fixed-dose combination medications for the treatment of hypertension: a critical review. J Clin Hypertens 1987;3:278-93
- Gupta AK, Arshad S, Poulter NR. Compliance, safety, and effectiveness of fixed-dose combinations of antihypertensive agents: a meta-analysis. Hypertension 2010;55:399-407
- Kirsten R, Neff J, Heintz B, et al. Influence of different bisoprolol doses on hemodynamics, plasma catecholamins, platelet aggregation, and α2- and β-receptors in hypertensive patients. J Cardiovasc Pharmacology 1986;8(Suppl 11):113-21
- Davidov ME, Singh SP, Vlachakis ND, et al. Bisoprolol, a once-a-day-beta-blocking agent for patients with mild to moderate hypertension. Clin Cardiol 1994;17:263-8
- Osterloh I. The safety of amlodipine. Am Heart J 1989;118:1114-20
- Pedrinelli R, Dell’Omo G, Melillo E, Mariani M. Amlodipine, enalapralil, and dependent leg edema in essential hypertension. Hypertension 2000;35:621-5